Aurora Cannabis Inc. (NYSE:ACB) trade volume has decreased by -10.64% as around 13,012,409 shares were sold when compared with its 50-day average volume of traded shares which is 14,561,229. At the moment, ACB is witnessing a downtrend, as it is trading -16.4% below its 20-day SMA, -32.43% below its 50-day SMA, and -21.71% below its 200-day SMA. The company runs an ROE of roughly 0%, with financial analysts predicting that their earnings per share growth will be around 0% per annum for the next five year. This will be compared to the 0% decrease witnessed over the past five years.

The last few days have been rough for Aurora Cannabis Inc. (ACB), as its price has decreased by -1.82% during the week. It has also performed poorly over the past three months, as it lost around -18.38% while it has so far retreated around -4.19% during the course of a year. The price of the stock went down by -$0.29 now trading at $5.4. Their shares witnessed a 38.46% increase from the 52-week low price of $3.9 they recorded on 2018-08-14. Even though it is still -131.85% behind the $12.52 high touched on 2018-10-16. The stock of ACB recorded -26.54% downtrend from the beginning of this year till date. The 12-month potential price target for Aurora Cannabis Inc. is set at $0. This target means that the stock has an upside potential to increase by -100% from the current trading price.

When giving their opinion, around 50% of Wall Street analysts, which represents 2 out of 4 rated the stock as a Buy. 2 brokerage firms of the remaining 50% rated the stock as a Hold with 0 analyst rating it as a sell. Overall, the number of aggregate ACB shares held by institutional investors represents 5.9% of total shares. 14 institutions entered new Aurora Cannabis Inc. (NYSE:ACB) positions, 18 added to their existing positions in these shares, 2 lowered their positions, and 1 exited their positions entirely.

The first technical resistance point for Aurora Cannabis Inc. (NYSE:ACB) will likely come at $5.59, marking a 3.4% premium to the current level. The second resistance point is at $5.78, about 6.57% premium to its current market price. On the other hand, inability to breach the immediate hurdles can drag it down to $5.16, the lower end of the range. ACB’s 14-day MACD is -0.34 and this negative figure indicates a downward trading trend. The company’s 14-day RSI (relative strength index) score is 35.91, which shows that its stock has been neutral. The 20-day historical volatility for the stock stands at 77.8 percent, which is low when compared to that of the 50-day’s 96.75 percent.

The shares of Chevron Corporation (NYSE:CVX) has decreased by -2.84%, and now trading at $117.24 on the Wall Street in the intra-day deal, with their shares traded now around 8,098,317. This is a rise of 1,302,577 shares over the average 6,795,740 shares that were traded daily over the last three months. The stock that is trading at $117.24 went higher by 9.02% from its 52-week low of $107.54 that it attained back on 2018-10-29. The stock recorded a 52-week high of $133.88 nearly 323 days ago on 2018-01-16.

CVX stock has performed well over the past 30 days, as it added 2.19% while its price plunged by -6.35% year-to-date (YTD). Looking at the last few days, it has been good for the stock, as it rose 1.76% over the last week. The stock’s 12-month potential target price is now at $145.14. This means that the stock price might likely increase by 23.8% from its current trading price.17 out of 23 Wall Street analysts which represents 73.91% rated the stock as a buy while the remaining 26.09 rated it as a hold, with 0 of analysts rating it as a sell.

Chevron Corporation (NYSE:CVX) has been utilizing an ROE that is roughly 9.4%, with stock analysts predicting that the company’s EPS for the next five years will go up by 58.26% per year, following the -22.3% drop that was witnessed during the past five years. The stock at the moment is on a downtrend, trading -0.46% below its 20-day SMA, -0.85% below its 50-day SMA, and -2.59% below its 200-day SMA. In percentage terms, the aggregate Chevron Corporation shares held by institutional investors is 67.2%. 81 institutions jumped in to acquire Chevron Corporation (CVX) fresh stake, 1024 added to their current holdings in these shares, 1010 lowered their positions, and 74 left no stake in the company.

The stock’s 9-day MACD is 1.71 and this positive figure indicates an upward trading trend. The company’s 9-day RSI score is 49.31, which shows that its stock has been neutral. The 20-day historical volatility for the shares stand at 28.2 percent, which is more when compared to that of the 50-day’s 26.64 percent. On the daily chart, we see that the stock could reach the first level of resistance at $119.86, sporting a 2.19% premium to the current level. The next resistance point is at $122.49, representing nearly 4.29% premium to the current market price of Chevron Corporation (CVX). On the other hand, failure to breach the immediate hurdles can drag it down to $114.44, the lower end of the range.